SSA Seeks Industry Help In Speeding Coverage For Orphan Drugs

Sponsors of drugs to treat disabling illnesses have an opportunity to work with the Social Security Administration to simplify eligibility determinations that could in turn make it easier for patients to obtain Medicare coverage for their treatments.